Select Bibliography

Filter by any of these (after searching):

CALGB-90102

AUTHOR ABSTRACT DEADLINES

A meeting abstract must be submitted by the first or corresponding author to the Alliance Publications Coordinator (publications@AllianceNCTN.org) at least two weeks prior to the meeting abstract submission deadline. For detailed information about Alliance Publications guidelines, please refer to the policies, along with the author abstract deadlines.

There are 3 items

Prognostic Model for Predicting Survival of Patients With Metastatic Urothelial Cancer Treated With Cisplatin-Based Chemotherapy

Apolo, Andrea B. , Ostrovnaya, Irina , Halabi, Susan ... - - J Natl Cancer Inst - 2013

Manuscript - Secondary-not-in-original - Primary - GU - CALGB-90102

External validation of prognostic models for overall survival (OS) in patients (pts) with advanced cancer (UC) treated with cisplatin-based chemotherapy.

Apolo, Andrea Borghese , Philips, George , Ostrovnaya, Irina ... - ASCO - J Clin Oncol - 2012

Abstract - Secondary-not-in-original - Primary - GU - CALGB-90102

A phase II trial of cisplatin (C), gemcitabine (G) and gefitinib for advanced urothelial tract carcinoma: results of Cancer and Leukemia Group B (CALGB) 90102

Philips, G. K. , Halabi, S. , Sanford, B. L. , Bajorin, D. ... - - Ann Oncol - 2009

Manuscript - Primary - Primary - GU - CALGB-90102